Pages that link to "Q44019185"

The following pages link to Novel mutations in domain I of SCN5A cause Brugada syndrome (Q44019185):

Displaying 17 items.

• Cardiac Na+ current regulation by pyridine nucleotides (Q24315557) (← links)
• Solution NMR structure of the C-terminal EF-hand domain of human cardiac sodium channel NaV1.5 (Q24324607) (← links)
• Physiological and Pathophysiological Insights of Nav1.4 and Nav1.5 Comparison (Q26772794) (← links)
• The genetic basis of Brugada syndrome: a mutation update (Q28252115) (← links)
• Genetics of Sudden Cardiac Death (Q34203505) (← links)
• Brugada syndrome: from cell to bedside (Q34667046) (← links)
• Unique mixed phenotype and unexpected functional effect revealed by novel compound heterozygosity mutations involving SCN5A. (Q34775754) (← links)
• The Use of Denaturing High-Performance Liquid Chromatography (DHPLC) for the Analysis of Genetic Variations: Impact for Diagnostics and Pharmacogenetics (Q35127771) (← links)
• A sodium channel pore mutation causing Brugada syndrome (Q35605502) (← links)
• Feasibility of an Assessment Tool for Children's Competence to Consent to Predictive Genetic Testing: a Pilot Study (Q36275078) (← links)
• Pharmacogenetics and cardiac ion channels (Q36339192) (← links)
• Characterization of N-terminally mutated cardiac Na(+) channels associated with long QT syndrome 3 and Brugada syndrome (Q43115368) (← links)
• A novel missense mutation in the SCN5A gene associated with Brugada syndrome bidirectionally affecting blocking actions of antiarrhythmic drugs (Q46475665) (← links)
• Population pharmacokinetic and pharmacodynamic analysis of a class IC antiarrhythmic, pilsicainide, in patients with cardiac arrhythmias (Q46882756) (← links)
• Rare autosomal dominant POLG1 mutation in a family with metabolic strokes, posterior column spinal degeneration, and multi-endocrine disease (Q48438460) (← links)
• Experimental Models of Brugada syndrome. (Q64946783) (← links)
• Brugada syndrome (Q84847446) (← links)